The most notable increase was Teva Pharmaceutical Industries Ltd (NYSE:TEVA), with an additional 7,569,450 shares, bringing the total to 8,997,400 shares. This adjustment represents a significant 530.

Teva stock retreated Wednesday after the pharmaceutical company reported a drop in fourth-quarter revenue.

Axsome Therapeutics, Inc. (NASDAQ:AXSM) signed a settlement agreement with Teva Pharmaceuticals Inc (NYSE:TEVA). The ...

We recently published a list of These 10 Stocks Were Wednesday’s Worst Performers. In this article, we are going to take a ...

Teva and its partner Sanofi say 47.8% of patients with ulcerative colitis who received a high dose of their drug duvakitug experienced clinical remission, compared with 20.5% who received a placebo.

Teva Pharmaceutical Industries ( NYSE:TEVA ) Full Year 2024 Results Key Financial Results Revenue: US$16.5b (up 4.4... This pharma stock has made strong gains over the past 12 months thanks to its ...

Teva Pharmaceutical Industries TEVA reported fourth-quarter 2024 adjusted earnings of 71 cents per share, which beat the ...

Pharmaceutical companies brace for the upcoming Trump administration. Teva Pharmaceuticals (TEVA) CEO Richard Francis joins Seana Smith and Madison Mills on Catalysts to discuss what both the ...

TEVA’s trailing and forward P/E were 872 and 7.61 respectively according to Yahoo Finance. 5 Highest Paying Countries for Pharmacists A close-up shot of various types of medicines on a table, ...

Morning Brief Co-Host Seana Smith sits down with Wealth! Host Brad Smith take a look at the top trending tickers on Yahoo Finance's platform. Teva Pharmaceutical Industries (TEVA) and Sanofi (SNY) ...